Correlation Between Genscript Biotech and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Genscript Biotech and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genscript Biotech and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genscript Biotech and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Genscript Biotech and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genscript Biotech with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genscript Biotech and Telix Pharmaceuticals.
Diversification Opportunities for Genscript Biotech and Telix Pharmaceuticals
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Genscript and Telix is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Genscript Biotech and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Genscript Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genscript Biotech are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Genscript Biotech i.e., Genscript Biotech and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between Genscript Biotech and Telix Pharmaceuticals
Assuming the 90 days horizon Genscript Biotech is expected to under-perform the Telix Pharmaceuticals. In addition to that, Genscript Biotech is 1.04 times more volatile than Telix Pharmaceuticals Limited. It trades about -0.01 of its total potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.0 per unit of volatility. If you would invest 1,426 in Telix Pharmaceuticals Limited on August 25, 2024 and sell it today you would lose (16.00) from holding Telix Pharmaceuticals Limited or give up 1.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Genscript Biotech vs. Telix Pharmaceuticals Limited
Performance |
| Timeline |
| Genscript Biotech |
| Telix Pharmaceuticals |
Genscript Biotech and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Genscript Biotech and Telix Pharmaceuticals
The main advantage of trading using opposite Genscript Biotech and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genscript Biotech position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.| Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. Zentalis Pharmaceuticals Llc | Genscript Biotech vs. Innovent Biologics |
| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |